|
|
||||||||
Department of Cardiovascular Surgery, Shiga University of Medical Science, Otsu City, Shiga, Japan
Accepted for publication June 7, 2010.
* Address correspondence to Dr Suzuki, Department of Cardiovascular Surgery, Shiga University of Medical Science, Otsu City, Shiga, Japan (Email: suzukit{at}belle.shiga-med.ac.jp).
| Abstract |
|---|
|
|
|---|
50%) has historically been recognized as a risk factor among patients undergoing coronary artery bypass grafting. Methods: From January 2002 to December 2008, a total of 665 patients, 268 of whom had significant LMCA disease, underwent isolated off-pump coronary artery bypass surgery at Shiga Medical University Hospital. We compared the clinical results in the 237 patients with LMCA stenosis (LMCA group) with those in the propensity score-matched 237 patients without LMCA stenosis (non-LMCA group). We performed off-pump surgery in all coronary artery bypass grafting cases with no exclusion criteria.
Results: All procedures were performed by off-pump technique without conversion to on-pump. Two patients in the LMCA group (2 of 237; 0.8%) and four in the non-LMCA group (4 of 237; 1.7%) died within 30 days after surgery. Follow-up was completed in 96.2% of the patients. The rates of six-year freedom from all cause death were 87.3% and 60.7% in the LMCA group and non-LMCA group, respectively (p = 0.17), and the corresponding rates for the combined endpoint of cardiac death, myocardial infarction, angina pectoris, repeat coronary intervention, and heart failure were 80.4% and 70.4% (p = 0.98). Multivariate Cox regression analysis revealed chronic renal failure as a statistically significant predictor for late cardiac event.
Conclusions: Off-pump coronary artery bypass grafting is feasible and safe in patients with critical LMCA stenosis and LMCA disease is not recognized as a risk factor after off-pump coronary artery bypass grafting in either the short or the long term.
| Introduction |
|---|
|
|
|---|
Left main coronary artery stenosis has historically been recognized as a risk factor for early death among patients undergoing CABG [5, 6]. A number of recent reports, however, have indicated the safety and efficacy of OPCAB in patients with LMCA disease [7–10]. There are, moreover, reports [11, 12] of similar long-term survival after CABG regardless of LMCA disease status.
We became skeptical as to whether LMCA stenosis was still a significant risk factor after CABG. The purpose of the present study was to compare short-term and long-term clinical outcome after OPCAB surgery between propensity-matched groups with and without LMCA disease.
| Patients and Methods |
|---|
|
|
|---|
From January 2002 to December 2008, a total of 665 patients, 268 of whom had significant LMCA disease, underwent isolated OPCAB surgery under a single surgeon (T.A.) at Shiga Medical University Hospital. We have calculated a propensity score for LMCA disease to get one-to-one match pairs with similar clinical characteristics. Logistic regression with backward selection was performed to calculate the propensity score. By matching propensity score, 237 pairs were successfully matched in a one-to-one manner. We compared the clinical results between these propensity-matched groups. We performed OPCAB in all CABG cases with no exclusion criteria. Patients with acute myocardial infarction were included, but patients who had undergone a salvage procedure were excluded from the study. Postoperative renal failure was defined as the requirement for hemodialysis. Postoperative stroke was defined as a new neurologic event persisting for more than 24 hours after onset and was confirmed by computed tomography. Follow-up was achieved by direct communication with the patient, the patient's family, or the attending physician. Significant LMCA disease was defined as LMCA with stenosis greater than 50%, assessed visually by the physician performing the coronary angiography.
Anesthetic and Surgical Techniques
A standard anesthetic technique was used for all patients. The induction of anesthesia was achieved with fentanyl citrate (5 to 10 µg/kg), thiopental (3 to 5 mg/kg), or propofol infusion (3 to 4 mg/kg/hour), and vecuronium bromide (0.1 mg/kg). Anesthesia was maintained with fentanyl, propofol (2 to 3 mg/kg), and low concentrations of sevoflurane as necessary. Anticoagulation was achieved with heparin (1 mg/kg) after the conduits were harvested. The activated clotting time was maintained at 250 seconds or greater. Heparin was reversed with protamine after completion of the anastomosis. Standard intraoperative monitoring techniques were used. Pulmonary artery flotation catheters were used routinely and provided continuous evaluation of cardiac output. Transesophageal echocardiography was used routinely.
All procedures were performed through a median sternotomy. The conduits (one or both internal thoracic arteries, the right gastroepiploic artery, and saphenous vein) were harvested and skeletonized. We used bilateral internal thoracic arteries routinely for two-vessel or three-vessel disease patients who required grafting to the left anterior descending artery and circumflex artery. A common combination for internal thoracic artery graft placement was in situ grafting of the left internal thoracic artery to the circumflex area and the right internal thoracic artery to the left anterior descending area. We also aggressively used the skeletonized right gastroepiploic artery to reconstruct the distal right coronary artery as an in situ graft. We used a suction-type mechanical stabilizer (Octopus 4.3; Medtronic, Minneapolis, MN) to immobilize the target coronary artery, but did not use heart positioning. An intracoronary shunt tube and carbon dioxide blower were used routinely. The distal anastomosis was constructed with 7-0 polypropylene using a standard technique. A red blood cell saving device was used in all cases.
Statistical Analysis
Data are presented as the mean ± standard deviation. Categoric variables were analyzed using the
2 or Fisher's exact test. Continuous variables were examined using the t test or the Mann-Whitney U test.
We have calculated a propensity score for LMCA disease to get one-to-one match pairs with similar clinical characteristics. Logistic regression with backward selection was performed to calculate the propensity score. The C statistic was calculated to assess the discriminatory ability of the model. Each patient with LMCA disease was then matched to one patient without LMCA disease using propensity scores identical to within 3%.
Univariate and multivariate Cox proportional hazard regression analyses were performed for the analysis of late mortality and cardiac event. The multivariate analyses were performed with a stepwise forward regression model in which each variable with a probability value of less than 0.20 in the univariate analysis was entered in the model. Actuarial survival and event-free survival curves were estimated using the Kaplan-Meier method comparing differences between groups with the log-rank test. Calculated p values of less than 0.05 were considered significant. Data were analyzed using SPSS 11.5.1 (SPSS Inc, Chicago, IL) for Windows (Microsoft Corp, Redmond, WA).
| Results |
|---|
|
|
|---|
|
|
|
|
|
| Comment |
|---|
|
|
|---|
Following the development of technology, pioneering cardiologists have recently performed percutaneous coronary intervention in patients with LMCA disease and reported good results compared with CABG [17–21]. However, the use of percutaneous coronary intervention for these patients is still controversial and requires additional supporting evidence.
Numerous studies [5, 6] have identified the presence of LMCA disease as an independent predictor of postoperative morbidity and mortality in patients undergoing CABG. Such reports were based upon data presented in the 1970s to 1990s, when the techniques of surgery, anesthesia, and medical management were less advanced than now. During the last two decades, there have been major improvements in almost all fields relating to the perioperative management of patients undergoing CABG. Coronary artery bypass grafting has also progressed thanks to better management, with options including more frequent use of arterial graft, more use of internal thoracic arteries, and improved techniques in off-pump surgery.
There have been many recent reports of complete revascularization achieved safely through OPCAB with excellent early-stage clinical outcomes, superior or equal to those of conventional CABG with cardiopulmonary bypass. However, there are still some patients who cannot be treated with OPCAB, such as those with a severe risk factor. While OPCAB for patients with LMCA stenosis remains challenging [4], a number of recent reports have indicated the safety and efficacy of the technique in LMCA stenosis patients [7–10]. Yeatman and colleagues [9] reported the safety and efficacy of OPCAB for critical LMCA disease in a comparison of 75 OPCAB cases and 312 conventional CABG procedures. Lu and colleagues [10] also evaluated OPCAB surgery in a comparison of on-pump surgery using a risk-adjusted model. In our OPCAB series, the number of distal anastomoses per patient was 3.34 in the LMCA group and 3.41 in the non-LMCA group, with complete revascularization achieved in 96.6% and 98.3%, respectively. There were thus no significant differences between the two groups. No patient in either group was converted from off-pump to on-pump. Operative mortality was 0.8% in the LMCA group and 1.7% in the non-LMCA group and postoperative morbidity was equally frequent in the two groups with no significant differences. These early-stage results of the study also indicated the feasibility and effectiveness of the OPCAB approach for patients with significant LMCA disease.
In contrast to previous studies, Cosgrove and colleagues [11] report that LMCA disease is not an independent risk factor for operative mortality after CABG. Since their report, several studies [11, 12, 22] have recorded equal early-stage survival in patients with LMCA stenosis compared with other patients and similar long-term survival after CABG. Jönsson and colleagues [22] demonstrated an improvement in surgical results over three decades (1970s to 1990) and the neutralization of LMCA stenosis as a risk factor for both early and late death during the 1990s. Indeed, there was a pronounced decrease over time in the risk of both early and late death in patients with LMCA undergoing CABG. Contributory to this improvement were technical advances in surgery, anesthesia, and intensive care management. Improvement in medical management, including the use of statins, an effective antithrombotic drug, and β-blocker, was also a factor.
Patients with LMCA stenosis have been recognized as having a poorer prognosis after CABG than those without. The present study showed a 6-year survival rate for all causes of death: 87.3% in the LMCA group and 60.7% in the non-LMCA group with no significant difference. Freedom from any cardiac event (cardiac death, myocardial infarction, angina pectoris, percutaneous coronary intervention, cardiac failure) was 80.4% in the LMCA group and 70.4% in the non-LMCA group. We found no significant difference in long-term clinical outcome between the two groups. In the present study, LMCA stenosis was thus not recognized as a risk factor after CABG in either short-term or long-term outcomes.
A limitation of the present study is that it is non-randomized and is a retrospective study comparing outcome in patients with and without LMCA disease undergoing OPCAB. Our study population was small, resulting in insufficient statistical power. However, all of the procedures were consecutive and conducted within a single institute by a single surgeon. Additionally, comparison of preoperative demographic and risk factors demonstrated that the two cohorts were well-matched. We concluded that OPCAB is feasible and safe in patients with critical LMCA stenosis and that LMCA disease is not a risk factor after OPCAB surgery in either the short- or long-term.
| References |
|---|
|
|
|---|
Related Article
This article has been cited by other articles:
![]() |
A. K. Sharma OPCAB Technique for High-Risk Patients Ann. Thorac. Surg., September 1, 2012; 94(3): 1036 - 1036. [Full Text] [PDF] |
||||
![]() |
H.-L. Gan, J.-Q. Zhang, W. Xiao, S. Zhao, F.-j. Huang, C.-x. Gu, C.-s. Lu, and P.-S. Wang Ostial left main coronary artery stenosis as an additional risk factor in off-pump coronary artery bypass grafting J. Thorac. Cardiovasc. Surg., January 1, 2012; 143(1): 103 - 110. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-B. Kim Invited Commentary Ann. Thorac. Surg., November 1, 2010; 90(5): 1506 - 1506. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |